Bonus Material-14_Roto - Thromboembolic disease 2025

Pdf Summary

This presentation by Dr. Dominick Roto covers key concepts in thromboembolic disease, focusing on the assessment, diagnosis, risk stratification, and treatment of deep vein thrombosis (DVT) and acute pulmonary embolism (PE), as well as the differential diagnosis of nonthrombotic pulmonary emboli.<br /><br />For DVT, clinical pretest probability is evaluated using tools like the Wells score, which stratifies risk into low, moderate, and high categories. Low-risk patients warrant D-dimer testing unless confounding conditions exist; moderate to high-risk patients generally require ultrasound. Treatment usually involves anticoagulation for at least three months, with duration depending on risk factors.<br /><br />Acute PE is common and carries significant mortality. Diagnosis is guided by Wells score categories prompting further testing with Pulmonary Embolism Rule-out Criteria (PERC), D-dimer, or CT angiography. Risk stratification hinges on hemodynamic status and right ventricular (RV) dysfunction, assessed via imaging and biomarkers. The European Society of Cardiology (ESC) guidelines recommend anticoagulation alone for low-risk patients, systemic thrombolytics for high-risk (massive) PE unless contraindicated, and anticoagulation with close monitoring for intermediate-risk cases, reserving thrombolysis for clinical deterioration.<br /><br />Pregnant patients require adapted diagnostic algorithms (e.g., Pregnancy-Adapted YEARS) with CT angiography preferred after chest X-ray; treatment differs pre- and postpartum, typically using low molecular weight heparin prepartum and considering direct oral anticoagulants postpartum based on breastfeeding status.<br /><br />Nonthrombotic PE causes include septic emboli, amniotic fluid embolism, air embolism, fat embolism, and pulmonary tumor thrombi, each with distinct presentations, imaging findings, and treatments—mostly supportive or targeted to underlying causes.<br /><br />Case scenarios illustrate clinical decision-making for DVT diagnosis, PE risk stratification, management choices, and recognizing nonthrombotic embolisms. Emphasis throughout is on applying guidelines to optimize patient care in thromboembolic disease.

Meta Tag

Concept Deep Vein Thrombosis

Concept Wells Criteria

Concept Pulmonary Embolism

Concept Anticoagulation

Concept Pretest Probability

Keywords

thromboembolic disease

deep vein thrombosis

pulmonary embolism

Wells score

D-dimer testing

ultrasound diagnosis

anticoagulation therapy

risk stratification

pregnancy-adapted YEARS

nonthrombotic embolism